This multi-year work culminated almost two years ago now with the complete synthesis of the Mycoplasma genitalium genome 4. At every stage, we've had to develop new methodology and tools.

In this application, ownership is claimed of an organism that contains a reduced version of the genome of Mycoplasma genitalium that is still capable of living freely, growing and replicating.

Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple ...

US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...

Leveraging gold-standard PCR technology, the cobas liat system claims to deliver outcomes in under 20 minutes.

Roche AG secured U.S. FDA 510(k) clearance for its cobas liat sexually transmitted infection (STI) multiplex assay panels. The tests, which also received a Clinical Laboratory Improvement Amendments ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...